Interview with Stefan Walzer
Key points:
- EU Health Technology Assessment (HTA)
- Current state
- Significant challenges ahead
- Stefan Walzer
- Market access expert
- Health economics
- Over two decades of experience
- European Joint Clinical Assessment (JCA)
- Introduction and implications
- Impact on pricing and clinical requirements
- Healthcare Community
- Agility and innovation
- Navigating regulatory environments
- Key Topics
- Pressures on pricing
- Clinical requirements
- Future of healthcare in Europe
This episode provides crucial insights into the evolving landscape of EU Health Technology Assessment (HTA) and the significant challenges ahead.
Stefan Walzer’s expertise sheds light on the pressures on pricing, clinical requirements, and the upcoming European Joint Clinical Assessment (JCA).
If you’re involved in the healthcare industry or have a keen interest in market access and health economics, this episode is a must-listen. Don’t keep these valuable insights to yourself—share this episode with your friends and colleagues who can benefit from understanding these pivotal developments.
Tune in now and join the conversation on shaping the future of healthcare in Europe.
